Efruxifermin in Non-Alcoholic Steatohepatitis: a Randomized, Double-Blind, Placebo-Controlled, Phase 2a Trial.
Nature Medicine（2021）
Key words
Biological therapy,Cardiovascular diseases,Drug development,Metabolic syndrome,Randomized controlled trials,Biomedicine,general,Cancer Research,Metabolic Diseases,Infectious Diseases,Molecular Medicine,Neurosciences
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined